Page 211 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 211
Viral Hepatitis: Hepatitis B & D - Experimental
P0529 ANTI CAPSID DRUGS HAP12 AND AT130 TARGET HBV CORE
PROTEIN NUCLEAR FUNCTIONS
Laura Belloni, Gianna Aurora Palumbo, Leonardo Lupacchini,
Lichun Li, Srinivas Reddy Chirapu, Ludovica Calvo, M. G. Finn,
Uri Lopatin, Adam Zlotnick, Massimo Levrero*, Italy
P0530 MYRCLUDEX-B INHIBITS ESTABLISHMENT OF HDV
SUPER-INFECTION IN HBV INFECTED MICE AND
REDUCES HDV VIREMIA IN STABLY HBV/HDV CO-
INFECTED MICE
Tassilo Volz*, Katja Giersch, Lena Allweiss, Oliver D. Bhadra,
Joerg Petersen, Ansgar W. Lohse, Marc Lütgehetmann, Stephan Urban,
Maura Dandri, Germany
P0531 TRANSGENIC MICE CARRYING HEPATITIS B VIRUS PRE-
S/S GENE CONTAINING THE RTA181T/SW172* MUTATION
DEVELOP HEPATOCELLULAR CARCINOMA
Chau-Ting Yeh*, Ming-Wei Lai, Kung-Hao Liang,Ya-Hui Huang, Taiwan
P0532 HBX –DLEU2 LNCRNA COMPLEX AFFECTS ePOSTERS
TRANSCRIPTION OF NEW TARGET PROMOTERS
Francesca Guerrieri*, Letizia Chiodo, Safaa Jeddari, Daniel D’Andrea,
Giancarlo Ruocco, Anna Tramontano, Massimo Levrero, Italy
P0533 THE EFFICACY OF ZINC FINGER ANTIVIRAL PROTEIN
AGAINST HEPATITIS B VIRUS TRANSCRIPTION AND
REPLICATION IN TANSGENIC MOUSE MODEL
En-Qiang Chen*, Hong Tang, Jie Dai, Lang Bai, China
P0534 HEPATITIS E VIRUS RNA REPLICATION IS ENSURED BY
UNPROCESSED ORF1 PROTEIN
Viet Loan Dao Thi, Suzanne U. Emerson, Tero Ahola,
Darius Moradpour, Jérôme Gouttenoire*, Switzerland
P0535 DIRECT ANTIVIRAL EFFECTS OF VARIOUS PATTERN
RECOGNITION RECEPTOR (PRR) AGONISTS IN HBV-
REPLICATING HEPATOCYTES
Julie Lucifora, Sarah Maadadi, Océane Floriot, Stephane Daffis,
Simon Fletcher, Fabien Zoulim, David Durantel*, France
Vienna, Austria • April 22–26, 2015 211
P0529 ANTI CAPSID DRUGS HAP12 AND AT130 TARGET HBV CORE
PROTEIN NUCLEAR FUNCTIONS
Laura Belloni, Gianna Aurora Palumbo, Leonardo Lupacchini,
Lichun Li, Srinivas Reddy Chirapu, Ludovica Calvo, M. G. Finn,
Uri Lopatin, Adam Zlotnick, Massimo Levrero*, Italy
P0530 MYRCLUDEX-B INHIBITS ESTABLISHMENT OF HDV
SUPER-INFECTION IN HBV INFECTED MICE AND
REDUCES HDV VIREMIA IN STABLY HBV/HDV CO-
INFECTED MICE
Tassilo Volz*, Katja Giersch, Lena Allweiss, Oliver D. Bhadra,
Joerg Petersen, Ansgar W. Lohse, Marc Lütgehetmann, Stephan Urban,
Maura Dandri, Germany
P0531 TRANSGENIC MICE CARRYING HEPATITIS B VIRUS PRE-
S/S GENE CONTAINING THE RTA181T/SW172* MUTATION
DEVELOP HEPATOCELLULAR CARCINOMA
Chau-Ting Yeh*, Ming-Wei Lai, Kung-Hao Liang,Ya-Hui Huang, Taiwan
P0532 HBX –DLEU2 LNCRNA COMPLEX AFFECTS ePOSTERS
TRANSCRIPTION OF NEW TARGET PROMOTERS
Francesca Guerrieri*, Letizia Chiodo, Safaa Jeddari, Daniel D’Andrea,
Giancarlo Ruocco, Anna Tramontano, Massimo Levrero, Italy
P0533 THE EFFICACY OF ZINC FINGER ANTIVIRAL PROTEIN
AGAINST HEPATITIS B VIRUS TRANSCRIPTION AND
REPLICATION IN TANSGENIC MOUSE MODEL
En-Qiang Chen*, Hong Tang, Jie Dai, Lang Bai, China
P0534 HEPATITIS E VIRUS RNA REPLICATION IS ENSURED BY
UNPROCESSED ORF1 PROTEIN
Viet Loan Dao Thi, Suzanne U. Emerson, Tero Ahola,
Darius Moradpour, Jérôme Gouttenoire*, Switzerland
P0535 DIRECT ANTIVIRAL EFFECTS OF VARIOUS PATTERN
RECOGNITION RECEPTOR (PRR) AGONISTS IN HBV-
REPLICATING HEPATOCYTES
Julie Lucifora, Sarah Maadadi, Océane Floriot, Stephane Daffis,
Simon Fletcher, Fabien Zoulim, David Durantel*, France
Vienna, Austria • April 22–26, 2015 211
